Tag: Inflammatory Bowel Disease

Three recently reported developments in inflammatory bowel disease (IBD) research underscore a growing shift towards mechanism-based, personalised treatment. The findings address long-standing questions about why Crohn’s disease and ulcerative colitis affect individuals differently and why many patients continue to experience disease instability despite advanced therapies. Background Context IBD encompasses a spectrum of chronic inflammatory conditions […]

Researchers have identified a previously unrecognised network of cells in the intestine that could offer new insights into tissue healing and inflammatory bowel disease. The discovery, announced by EurekAlert!, may help explain why some patients experience impaired gut repair and could inform future therapeutic strategies for Crohn’s disease and ulcerative colitis. Background Context The intestinal […]

Researchers from the University of Oxford, Newcastle University, and the University of Cambridge have identified autoantibodies against interleukin-10 (IL-10) in approximately 3.5% of inflammatory bowel disease (IBD) patients, offering a biological explanation for a genetic marker previously linked to severe disease and pointing toward more targeted treatment strategies. Background Context Interleukin-10 is a key regulatory […]

Duvakitug, an investigational monoclonal antibody targeting interleukin-23, has demonstrated efficacy as an induction therapy for patients with inflammatory bowel disease (IBD), according to new research reported in MedPage Today. The findings add to the evolving landscape of advanced biologics for Crohn’s disease and ulcerative colitis. Background Context Interleukin-23 (IL-23) is a pro-inflammatory cytokine that plays […]